Quantum-Si Incorporated (NASDAQ:QSI – Get Free Report) was the recipient of unusually large options trading on Wednesday. Investors bought 3,845 call options on the company. This represents an increase of 134% compared to the typical volume of 1,644 call options.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on QSI shares. Weiss Ratings raised shares of Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, September 24th. HC Wainwright reissued a “buy” rating and set a $4.00 price target on shares of Quantum-Si in a research note on Tuesday. Alliance Global Partners restated a “buy” rating on shares of Quantum-Si in a report on Friday, August 14th. Finally, Wall Street Zen raised shares of Quantum-Si from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $2.50.
View Our Latest Analysis on Quantum-Si
Institutional Inflows and Outflows
Quantum-Si Stock Performance
NASDAQ:QSI traded up $0.12 during trading hours on Wednesday, hitting $1.08. The stock had a trading volume of 6,143,822 shares, compared to its average volume of 4,428,813. The business’s 50 day moving average is $0.77 and its 200-day moving average is $0.87. The company has a market cap of $235.52 million, a price-to-earnings ratio of -2.36 and a beta of 3.25. Quantum-Si has a one year low of $0.69 and a one year high of $3.10.
Quantum-Si (NASDAQ:QSI – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.11) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.11). Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. The company had revenue of $0.34 million for the quarter, compared to analysts’ expectations of $0.30 million. On average, sell-side analysts anticipate that Quantum-Si will post -0.47 EPS for the current fiscal year.
Quantum-Si Company Profile
Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.
Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.
See Also
- Five stocks we like better than Quantum-Si
- 3 Healthcare Dividend Stocks Offering More Than Just Income
- AI Uncertainty Is Rising, But These 3 Chip ETFs Still Have Momentum
- Arhaus Has New Momentum—Could Other Furniture Stocks Be Next?
- Can Boxabl Turn Modular Homes Into AI Data Center Infrastructure?
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
